The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
COVID-19, Hyperglycemia, and New-Onset Diabetes
Open accessAbstract
Certain chronic comorbidities, including diabetes, are highly prevalent in people with coronavirus disease 2019 (COVID-19) and are associated with an increased risk of severe COVID-19 and mortality. Mild glucose elevations are also common in COVID-19 patients and associated with worse outcomes even in people without diabetes. Several studies have recently reported new-onset diabetes associated with COVID-19. The phenomenon of new-onset diabetes following admission to the hospital has been observed previously with other viral infections and acute illnesses. The precise mechanisms for new-onset diabetes in people with COVID-19 are not known, but it is likely that a number of complex interrelated processes are involved, including previously undiagnosed diabetes, stress hyperglycemia, steroid-induced hyperglycemia, and direct or indirect effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the β-cell. There is an urgent need for research to help guide management pathways for these patients. In view of increased mortality in people with new-onset diabetes, hospital protocols should include efforts to recognize and manage acute hyperglycemia, including diabetic ketoacidosis, in people admitted to the hospital. Whether new-onset diabetes is likely to remain permanent is not known, as the long-term follow-up of these patients is limited. Prospective studies of metabolism in the setting of postacute COVID-19 will be required to understand the etiology, prognosis, and treatment opportunities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., Kang, L., Guo, L., Liu, M., Zhou, X., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32656-8 · Cited by 4,084
Retracted2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
Ahlqvist, E., Storm, P., Käräjämäki, A., Martinell, M., Dorkhan, M., Carlsson, A., Vikman, P., Prasad, R. B., Aly, D. M., Almgren, P., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30051-2 · Cited by 2,335
Capes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187 · cited 4×
“Stress hyperglycemia is a sign of relative insulin deficiency, which is associated with increased lipolysis and increased circulating free fatty acids seen in acute illness such as myocardial infarction or severe infections (27).”
BackgroundInfluentialHigh-dimensional characterization of post-acute sequelae of COVID-19
Al-Aly, Z., Xie, Y., & Bowe, B. (2021) · Nature · doi:10.1038/s41586-021-03553-9 · Cited by 1,518 · cited 1×
“Department of Veterans Affairs reported a higher burden of new-onset diabetes 6 months following COVID-19 (61).”
BackgroundNorhammar, A., Tenerz, Å., Nilsson, G., Hamsten, A., Efendíc, S., Rydén, L., & Malmberg, K. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09089-x · Cited by 1,112
Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes
Yang, J.-K., Lin, S.-S., Ji, X.-J., & Guo, L.-M. (2010) · Acta Diabetologica · doi:10.1007/s00592-009-0109-4 · Cited by 1,084
[A pathological report of three COVID-19 cases by minimal invasive autopsies].
Yao, X. H., Li, T. Y., He, Z. C., Ping, Y. F., Liu, H. W., Yu, S. C., Mou, H. M., Wang, L. H., Zhang, H. R., Fu, W. J., et al. (2020) · PubMed · doi:10.3760/cma.j.cn112151-20200312-00193 · Cited by 963
Practical recommendations for the management of diabetes in patients with COVID-19
Bornstein, S. R., Rubino, F., Khunti, K., Mingrone, G., Hopkins, D., Birkenfeld, A. L., Boehm, B., Amiel, S., Holt, R. I., Skyler, J. S., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30152-2 · Cited by 955
Self-citationPost-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study
Ayoubkhani, D., Khunti, K., Nafilyan, V., Maddox, T., Humberstone, B., Diamond, I., & Banerjee, A. (2021) · BMJ · doi:10.1136/bmj.n693 · Cited by 832
Self-citationNew-onset diabetes in Covid-19
Rubino, F., Amiel, S. A., Zimmet, P., Alberti, G., Bornstein, S., Eckel, R. H., Mingrone, G., Boehm, B., Cooper, M. E., Chai, Z., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2018688 · Cited by 801
Self-citationYang, J. K., Feng, Y., Yuan, M. Y., Yuan, S. Y., Fu, H. J., Wu, B. Y., Sun, G. Z., Yang, G. R., Zhang, X. L., Wang, L., et al. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01861.x · Cited by 794
Zelniker, T. A., Wiviott, S. D., Raz, I., Im, K., Goodrich, E. L., Furtado, R. H. M., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.038868 · Cited by 781 · cited 2×
“SGLT2i have also been shown to reduce hospitalization for heart failure and may reduce the risk of death from noncardiovascular causes (51).”
BackgroundBode, B., Garrett, V., Messler, J., McFarland, R., Crowe, J., Booth, R., & Klonoff, D. C. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820924469 · Cited by 766
ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection
Liu, F., Long, X., Zhang, B., Zhang, W., Chen, X., & Zhang, Z. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.04.040 · Cited by 718
Yeung, W.-C. G., Rawlinson, W. D., & Craig, M. E. (2011) · BMJ · doi:10.1136/bmj.d35 · Cited by 511
COVID ‐19 infection may cause ketosis and ketoacidosis
Li, J., Wang, X., Chen, J., Zuo, X., Zhang, H., & Deng, A. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14057 · Cited by 455
Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis
White, D. L., Ratziu, V., & El-Serag, H. B. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.006 · Cited by 451
Singh, A. K., Gillies, C. L., Singh, R., Singh, A., Chudasama, Y., Coles, B., Seidu, S., Zaccardi, F., Davies, M. J., & Khunti, K. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14124 · Cited by 414
Self-citationSARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment
Wu, C.-T., Lidsky, P. V., Xiao, Y., Lee, I. T., Cheng, R., Nakayama, T., Jiang, S., Demeter, J., Bevacqua, R. J., Chang, C. A., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.05.013 · Cited by 364
New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K.
Unsworth, R., Wallace, S., Oliver, N. S., Yeung, S., Kshirsagar, A., Naidu, H., Kwong, R. M. W., Kumar, P., & Logan, K. M. (2020) · Diabetes Care · doi:10.2337/dc20-1551 · Cited by 361
Wang, S., Ma, P., Zhang, S., Song, S., Wang, Z., Ma, Y., Xu, J., Wu, F., Duan, L., Yin, Z., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05209-1 · Cited by 325
Kamrath, C., Mönkemöller, K., Biester, T., Rohrer, T. R., Warncke, K., Hammersen, J., & Holl, R. W. (2020) · JAMA · doi:10.1001/jama.2020.13445 · Cited by 310
Li, H., Tian, S., Chen, T., Cui, Z., Shi, N., Zhong, X., Qiu, K., Zhang, J., Zeng, T., Chen, L., et al. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14099 · Cited by 272
Alraddadi, B. M., Watson, J. T., Almarashi, A., Abedi, G. R., Turkistani, A., Sadran, M., Housa, A., Almazroa, M. A., Alraihan, N., Banjar, A., et al. (2016) · Emerging Infectious Diseases · doi:10.3201/eid2201.151340 · Cited by 269
Proportion of newly diagnosed diabetes in COVID ‐19 patients: A systematic review and meta‐analysis
Sathish, T., Kapoor, N., Cao, Y., Tapp, R. J., & Zimmet, P. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14269 · Cited by 251
Kosiborod, M. N., Esterline, R., Furtado, R. H. M., Oscarsson, J., Gasparyan, S. B., Koch, G. G., Martinez, F., Mukhtar, O., Verma, S., Chopra, V., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00180-7 · Cited by 243
Fadini, G. P., Morieri, M. L., Boscari, F., Fioretto, P., Maran, A., Busetto, L., Bonora, B. M., Selmin, E., Arcidiacono, G., Pinelli, S., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108374 · Cited by 231
Hyperglycemia Induced by Glucocorticoids in Nondiabetic Patients: A Meta-Analysis
Liu, X.-X., Zhu, X.-M., Miao, Q., Ye, H.-Y., Zhang, Z.-Y., & Li, Y.-M. (2014) · Annals of Nutrition and Metabolism · doi:10.1159/000365892 · Cited by 226
Fignani, D., Licata, G., Brusco, N., Nigi, L., Grieco, G. E., Marselli, L., Overbergh, L., Gysemans, C., Colli, M. L., Marchetti, P., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.596898 · Cited by 205
Self-citationPotere, N., Valeriani, E., Candeloro, M., Tana, M., Porreca, E., Abbate, A., Spoto, S., Rutjes, A. W. S., & Di Nisio, M. (2020) · Critical Care · doi:10.1186/s13054-020-03022-1 · Cited by 193
Smith, S. M., Boppana, A., Traupman, J. A., Unson, E., Maddock, D. A., Chao, K., Dobesh, D. P., Brufsky, A., & Connor, R. I. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26227 · Cited by 189
Review of Infectious Etiology of Acute Pancreatitis
Rawla, P., Bandaru, S. S., & Vellipuram, A. R. (2017) · Gastroenterology Research · doi:10.14740/gr858w · Cited by 179
Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report
Hollstein, T., Schulte, D. M., Schulz, J., Glück, A., Ziegler, A. G., Bonifacio, E., Wendorff, M., Franke, A., Schreiber, S., Bornstein, S. R., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00281-8 · Cited by 176
Mechanisms of Coxsackievirus-Induced Damage to Human Pancreaticβ -Cells1
Roivainen, M., Rasilainen, S., Ylipaasto, P., Nissinen, R., Ustinov, J., Bouwens, L., Eizirik, D. L., Hovi, T., & Otonkoski, T. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6306 · Cited by 173
Coppelli, A., Giannarelli, R., Aragona, M., Penno, G., Falcone, M., Tiseo, G., Ghiadoni, L., Barbieri, G., Monzani, F., Virdis, A., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1380 · Cited by 169
Self-citationDid the COVID-19 Lockdown Affect the Incidence of Pediatric Type 1 Diabetes in Germany?
Tittel, S. R., Rosenbauer, J., Kamrath, C., Ziegler, J., Reschke, F., Hammersen, J., Mönkemöller, K., Pappa, A., Kapellen, T., & Holl, R. W. (2020) · Diabetes Care · doi:10.2337/dc20-1633 · Cited by 165
Kusmartseva, I., Wu, W., Syed, F., Van Der Heide, V., Jorgensen, M., Joseph, P., Tang, X., Candelario-Jalil, E., Yang, C., Nick, H., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.005 · Cited by 165
Seidu, S., Gillies, C., Zaccardi, F., Kunutsor, S. K., Hartmann‐Boyce, J., Yates, T. E., Singh, A. K., Davies, M. J., & Khunti, K. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.176 · Cited by 154
Self-citationAccili, D. (2021) · Nature Metabolism · doi:10.1038/s42255-020-00339-7 · Cited by 142
New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic
Salmi, H., Heinonen, S., Hästbacka, J., Lääperi, M., Rautiainen, P., Miettinen, P. J., Vapalahti, O., Hepojoki, J., & Knip, M. (2021) · Archives of Disease in Childhood · doi:10.1136/archdischild-2020-321220 · Cited by 136
Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the U.S.
Ebekozien, O. A., Noor, N., GALLAGHER, M. P., & Alonso, G. T. (2020) · Diabetes Care · doi:10.2337/dc20-1088 · Cited by 134
Multi-organ impairment in low-risk individuals with long COVIDPreprint
Dennis, A., Wamil, M., Kapur, S., Alberts, J., Badley, A. D., Decker, G. A., Rizza, S. A., Banerjee, R., & Banerjee, A. (2020) · medRxiv · doi:10.1101/2020.10.14.20212555 · Cited by 122
Abdelhamid, Y. A., Kar, P., Finnis, M., Phillips, L. K., Plummer, M. P., Shaw, J. E., Horowitz, M., & Deane, A. M. (2016) · Critical Care · doi:10.1186/s13054-016-1471-6 · Cited by 120
The high incidence of steroid-induced hyperglycaemia in hospital
Fong, A. C., & Cheung, N. W. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.12.023 · Cited by 109
Covid-19 and Diabetes: A Complex Bidirectional Relationship
Muniangi-Muhitu, H., Akalestou, E., Salem, V., Misra, S., Oliver, N. S., & Rutter, G. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.582936 · Cited by 104
COVID‐19 and diabetes: Insulin requirements parallel illness severity in critically unwell patients
Wu, L., Girgis, C. M., & Cheung, N. W. (2020) · Clinical Endocrinology · doi:10.1111/cen.14288 · Cited by 95
McGlacken-Byrne, S. M., Drew, S., Turner, K., Peters, C. J., & Amin, R. (2021) · Diabetic Medicine · doi:10.1111/dme.14640 · Cited by 91
Pasquel, F. J., Messler, J., Booth, R., Kubacka, B., Mumpower, A., Umpierrez, G. E., & Aloi, J. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.1091 · Cited by 88
Zhang, J., Kong, W., Xia, P., Xu, Y., Li, L., Li, Q., Li, Y., Wei, Q., Wang, H., Li, H., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00525 · Cited by 82
Protracted ketonaemia in hyperglycaemic emergencies in COVID-19: a retrospective case series
Armeni, E., Aziz, U., Qamar, S., Nasir, S., Nethaji, C., Negus, R. P. M., Murch, N., Beynon, H. C., Bouloux, P. M., Rosenthal, M. J., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30221-7 · Cited by 78
Decoding the unknowns in long covid
Altmann, D. M., & Boyton, R. J. (2021) · BMJ · doi:10.1136/bmj.n132 · Cited by 71
Ghosh, A., Anjana, R. M., Rani, C. S. S., Rani, S. J., Gupta, R., Jha, A., Gupta, V. K., Kuchay, M. S., Luthra, A., Durani, S., et al. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.12.033 · Cited by 69
New-Onset Diabetes After Acute and Critical Illness
Jivanji, C. J., Asrani, V. M., Windsor, J. A., & Petrov, M. S. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.12.020 · Cited by 66
A systematic scoping review on the consequences of stress-related hyperglycaemia
Olariu, E., Pooley, N., Danel, A., Miret, M., & Preiser, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194952 · Cited by 65
Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells
Shaharuddin, S. H., Wang, V., Santos, R. D. S., Gross, A. R., Wang, Y., Jawanda, H., Zhang, Y., Hasan, W., Garcia, G., Arumugaswami, V., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.678482 · Cited by 59
Kuchay, M. S., Reddy, P. K., Gagneja, S., et al. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.10.015 · Cited by 49
Liu, Y., Lu, R., Wang, J., Cheng, Q., Zhang, R., Zhang, S., Le, Y., Wang, H., Xiao, W., Gao, H., et al. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00717-6 · Cited by 45
New onset COVID-19–related diabetes: an indicator of mortalityPreprint
Yang, J., Jin, J., Liu, S., Bai, P., He, W., Wu, F., Liu, X., Chai, Z., & Han, D. (2020) · medRxiv · doi:10.1101/2020.04.08.20058040 · Cited by 43
Distinguishing the real from the hyperglycaemia: does COVID-19 induce diabetes?
Atkinson, M. A., & Powers, A. C. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00087-5 · Cited by 34
Steroid-induced hyperglycaemia in hospitalised patients: does it matter?
Cheung, N. W. (2016) · Diabetologia · doi:10.1007/s00125-016-4116-z · Cited by 19
Cited by
Risks and burdens of incident diabetes in long COVID: a cohort study
Xie, Y., & Al-Aly, Z. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00044-4 · Cited by 564
Hyperglycemic crises in adults with diabetes: a consensus report
Umpierrez, G. E., Davis, G. M., ElSayed, N. A., Fadini, G. P., Galindo, R. J., Hirsch, I. B., Klonoff, D. C., McCoy, R. G., Misra, S., Gabbay, R. A., et al. (2024) · Diabetes Care · doi:10.2337/dci24-0032 · Cited by 278
Self-citationGlucocorticoid-Induced Hyperglycemia: A Neglected Problem
Cho, J.-H., & Suh, S. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2024.1951 · Cited by 63
Practical Guide to Glucocorticoid Induced Hyperglycaemia and Diabetes
Barker, H. L., Morrison, D., Llano, A., Sainsbury, C. A. R., & Jones, G. C. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01393-6 · Cited by 58
Metadata
- Authors
- Khunti, K., Del Prato, S., Mathieu, C., Kahn, S. E., Gabbay, R. A., & Buse, J. B.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2021-10-08
- Volume
- 44
- Issue
- 12
- Pages
- 2645-2655
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W3203443071
- Cited by
- 320
- References
- 61
- FWCI
- 19.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.